<unk>  (INN), (BMS-986001) is an investigational new drug being developed by Bristol Myers-Squibb for the treatment of HIV infection. It was originally developed at Yale University.
Censavudine
Saquinavir
Brivudine
Fostemsavir
Stavudine
Coronavir
Entecavir
Ritonavir